Allergy Therapeutics, a specialty pharmaceutical company, announced the appointment of Nick Wykeman to the board as finance director.
Mr. Wykeman was most recently at Skyepharma PLC until August 2015 where he was the Group Financial Controller for six years.

Prior to that, he had also worked at Quest International (a part of ICI PLC) as the Group Financial Controller (Special Projects), following six years at Deloitte & Touche.

Mr. Wykeman has a BSc (Hons) in Economics and is a qualified accountant, being a member of the Institute of Chartered Accountants of England and Wales. ■

• Virgin Money Holdings to appoint Amy Stirling to board
• Bovis Homes appoints Mike Stansfield as director
• Flybe Group promotes Ian Milne to permanent CFO
• Pennant International Group appoints Joseph Clements to board
• Capita appoints Jonathan Lewis as CEO

---

More inside POST